Ashoke Khanwalkar, MD
Otolaryngology · Aurora, CONPI 1174917371
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,672 of the $27,594 with a category attached, or 82.2%. GSK accounts for 62.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $17,408 and has fallen 65.3% since, to $6,033 in 2025. Among otolaryngology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $438.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$17K
- Regeneron$5K
- Aerin Medical Inc.$2K
- Olympus Corporation Of The Americas$1K
- Medtronic$663
- Intersect ENT, Inc.$386
- plus $792 from 4 others
Across 12 payments — averaging $2740.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$33K
What the payments were for
- Consulting fees$22,67282%
- Travel & lodging$1,7376%
- Food & beverage$3,12111%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $17,260 |
| Regeneron | 2 | $5,460 |
| Aerin Medical Inc. | 9 | $1,826 |
| Olympus Corporation Of The Americas | 10 | $1,208 |
| Medtronic | 8 | $663 |
| Intersect ENT, Inc. | 3 | $386 |
| Stryker | 3 | $334 |
| Integra Lifesciences Corporation | 6 | $257 |
| AstraZeneca | 1 | $112 |
| Sanofi | 2 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$5,702
- DUPIXENT$5,460
- VIVAER STYLUS$1,223
- PK Diego$1,025
- Celon System$1,025
- Olympus ENT Instruments$1,025
- PROPEL$865
- RHINAER STYLUS$823
- ENTELLUS - XPRESS ENT DILATION SYSTEM$313
How this compares
$27,594 in reported general payments places this provider in the 90th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 97 | $4,171 |
| Budesonide | 16 | $3,190 |
| Mupirocin | 41 | $652 |
| Azelastine Hcl | 16 | $390 |
| Fluticasone Propionate | 16 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $141 |
| Oxycodone Hcl | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Aurora
- Vijay RamakrishnanAurora$128K
- Andrew WinklerAurora$68K
- Stephen CassAurora$11K
- Herman JenkinsAurora$5K
- Anne GetzAurora$5K
- Todd KingdomAurora$3K
- Geoffrey FerrilAurora$3K
- Brian CervenkaAurora$3K
- Joseph GonzalezAurora$2K
- Kimberly NelsonAurora$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.